A rating of 29 puts Seres Therapeutics Inc (MCRB) near the top of the Healthcare sector according to InvestorsObserver.
Seres Therapeutics Inc's score of 29 means that it ranks higher than 29% of stocks in the sector. In addition, its overall score of 8 ranks it higher than 8% of all stocks.
MCRB has an Overall Score of 8. Find out what this means to you and get the rest of the rankings on MCRB!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 8 would rank higher than 8 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease.
These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Seres Therapeutics Inc Stock Today?
Seres Therapeutics Inc (MCRB) stock is trading at $1.11 as of 9:32 AM on Tuesday, Nov 28, a decline of -$0.05, or -4.74% from the previous closing price of $1.16. The stock has traded between $1.11 and $1.13 so far today. Volume today is less active than usual. So far 4,660 shares have traded compared to average volume of 4,824,819 shares.
Click Here to get the full Stock Report for Seres Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter